Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development
AUTOR(ES)
Tse, Sze-Wah, Radtke, Andrea J, Zavala, Fidel
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2011-08
RESUMO
CD8+ T cells against malaria liver stages represent a major protective immune mechanism against infection. Following induction in the peripheral lymph nodes by dendritic cells (DCs), these CD8+ T cells migrate to the liver and eliminate parasite infected hepatocytes. The processing and presentation of sporozoite antigen requires TAP mediated transport of major histocompatibility complex class I epitopes to the endoplasmic reticulum. Importantly, in DCs this process is also dependent on endosome-mediated cross presentation while this mechanism is not required for epitope presentation on hepatocytes. Protective CD8+ T cell responses are strongly dependent on the presence of CD4+ T cells and the capacity of sporozoite antigen to persist for a prolonged period of time. While human trials with subunit vaccines capable of inducing antibodies and CD4+ T cell responses have yielded encouraging results, an effective anti-malaria vaccine will likely require vaccine constructs designed to induce protective CD8+ T cells against malaria liver stages.
Documentos Relacionados
- Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview
- Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
- Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA
- Induction of Autoreactive CD8+ Cytotoxic T Cells during Theiler's Murine Encephalomyelitis Virus Infection: Implications for Autoimmunity
- Kunjin Virus Replicon Vaccine Vectors Induce Protective CD8+ T-Cell Immunity